Upload Avatar (500 x 500)
Na Kong
kongna@zju.edu.cn
Chinese, English
Zhejiang
Zhejiang University
Medical
  • 2017-2018 Joint PhD: Harvard Medical School
  • 2019-2022 Postdoctoral Researcher: Harvard Medical School
  • Achievement: Developed a 'stimulus-responsive' mRNA delivery platform
  • Achievement: Developed the world's first adhesive mRNA drug delivery platform
  • Achievement: Published review paper in Chemical Society Reviews
  • 2022-Present - Zhejiang University Medical Center - Researcher
  • 2019-2022 - Harvard Medical School - Postdoctoral Researcher
  • 2017-2018 - Harvard Medical School - Joint PhD
  • National Youth Talent Program
Nucleic Acid Drugs
RNA Therapy
Biomaterials
Biomedical Engineering
Drug Delivery
  • Stimulus-responsive mRNA delivery platform, Na Kong, 2019
  • Adhesive mRNA drug delivery platform, Na Kong, 2022
  • Emerging mRNA technologies: delivery strategies and biomedical applications, Na Kong, 2022
Nucleic Acid Drugs Rna Therapy Biomaterials Biomedical Engineering Drug Delivery Mrna Circrna Tumor Targeting Protein Expression Clinical Translation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.